Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Kunshen, Liu"'
Autor:
Yaomeng Huang, Tongxin Li, Shichao Gao, Shuyu Li, Xiaoran Zhu, Ying Li, Dangyang Liu, Weimin Li, Linquan Yang, Kunshen Liu, Zheng Zhang, Chao Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Dilated cardiomyopathy (DCM), a specific form of cardiomyopathy, frequently presents clinically with either left ventricular or biventricular enlargement, often leading to progressive heart failure. In recent years, the application of bio
Externí odkaz:
https://doaj.org/article/9aff38fb058c41d1bbdd4d543b320403
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background Arginine vasopressin dependent antidiuresis plays a key role in water‐sodium retention in heart failure. In recent years, the role of glucocorticoids in the control of body fluid homeostasis has been extensively investigated. Glucocortic
Externí odkaz:
https://doaj.org/article/b91f26e94a9a492ebe597aa74ce517a6
Autor:
Feiming Ye, Xiaofeng Wang, Shulin Wu, Shumei Ma, Yu Zhang, Gang Liu, Kunshen Liu, Zhiming Yang, Xiaohua Pang, Li Xue, Shijuan Lu, Ming Zhong, Jing Li, Hao Yu, Donghua Lou, Dongyang Cui, Xiaojie Xie, Jian’an Wang
Publikováno v:
Journal of the American College of Cardiology. 80:584-594
Ivabradine has potent actions in reducing heart rate and improving clinical outcomes of chronic heart failure with reduced ejection fraction (HFrEF). At present, only the short-acting formulation of ivabradine is available that needs to be administer
Publikováno v:
Annals of Nuclear Medicine. 35:187-194
Renal scintigraphy with 99mTc-diethylenetriaminepentaacetic acid (DTPA) may be used to study renal perfusion (RP) in heart failure (HF) patients. The goal of this study was to establish a new method to assess RP in patients with systolic HF. In this
Publikováno v:
Journal of cardiovascular pharmacology. 80(3)
Glucocorticoid receptors are essential for normal development and stress responses. Their role in H 2 O and Na + metabolism, especially in chronic heart failure (CHF), is not well defined. In a previous study, we found that glucocorticoids potentiate
Publikováno v:
International Journal of General Medicine
Shuyu Li,1,2 Qingzhen Zhao,1 Yuzhi Zhen,1 Lizhuo Li,1 Yiqing Mi,1 Tongxin Li,1 Kunshen Liu,1 Chao Liu1 1The First Cardiology Division, First Affiliated Hospital of Hebei Medical University, Shijiazhuang, 050022, Peopleâs Republic of China; 2The
Autor:
Haifang, Ma, Xian, Gao, Pei, Yin, Qingzhen, Zhao, Yuzhi, Zhen, Yu, Wang, Kunshen, Liu, Chao, Liu
Publikováno v:
Annals of nuclear medicine. 35(2)
Renal scintigraphy withIn this retrospective, single-center, observational study, 86 subjects with left ventricular ejection fraction ≤ 45% and 31 age-matched subjects without HF underwent renal scintigraphy withRP in HF was impaired despite compar
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Arginine vasopressin dependent antidiuresis plays a key role in water‐sodium retention in heart failure. In recent years, the role of glucocorticoids in the control of body fluid homeostasis has been extensively investigated. Glucocortic
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15607 (2010)
Atrial natriuretic peptide (ANP) provides a potent defense mechanism against volume overload in mammals. Its primary receptor, natriuretic peptide receptor-A (NPR-A), is localized mostly in the kidney, but also is found in hypothalamic areas involved
Externí odkaz:
https://doaj.org/article/2115802171f7458b9fda5af880971887
Autor:
Chao Liu, Kunshen Liu
Publikováno v:
JACC: Heart Failure. 8:153
We read with great interest the recent report and editorial comment that discussed the effect of systemic corticosteroid therapy in heart failure (HF) and value of evidence from real-world experience ([1][1],[2][2]). Defining glucocorticoid action is